Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 204 across all filing types
Latest filing 2024-09-07 AGM Information
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is a notice and accompanying materials for the 37th Annual General Meeting (AGM) of Ortin Global Limited, including details about the meeting date, agenda items such as adoption of audited financial statements, appointment and reappointment of directors, and other resolutions to be considered at the AGM. It contains corporate information, board of directors, committees, and statutory auditor details, which are typical components of AGM materials. The document is lengthy (15,000 characters) and includes substantive content related to the AGM, not just a brief announcement or a link to a report. Therefore, it fits the category of AGM Information (AGM-R) rather than a report publication announcement or regulatory filing. There is no indication that this is a full annual report (10-K) or an earnings release (ER), nor is it a management report or proxy solicitation. The focus is clearly on the AGM notice and related information for shareholders to consider at the meeting.
2024-09-07 English
Name and Symbol Change
Regulatory Filings Classification · 95% confidence The document is a circular from the National Stock Exchange of India announcing a change in the name and symbol of a listed company, Ortin Laboratories Limited, effective from a specified date. It is a regulatory announcement related to listing information rather than a financial report, management change, or other detailed filings. The document is short (924 characters) and serves as an official notice to exchange members about the name and symbol change. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-29 English
Appointment
Regulatory Filings
2024-08-14 English
Appointment
Regulatory Filings
2024-08-14 English
Appointment
Regulatory Filings
2024-08-14 English
Appointment
Regulatory Filings
2024-08-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.